Safety and efficacy of ombitasvir – 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens
暂无分享,去创建一个
J. Slim | J. Eron | M. Sulkowski | P. Ruane | J. Lalezari | J. Gathe | R. Trinh | Barbara Da Silva-Tillmann | M. Co | A. Khatri | R. Elion | L. Fredrick | G. Blick | Yiran B. Hu | Chia Wang | Krystal Gibbons | R. D'Amico | Amit Khatri